BioCryst Pharmaceuticals, Inc. (BCRX)

NASDAQ: BCRX · Real-Time Price · USD

10.34

+0.37 (3.71%)

At close: May 12, 2025, 4:00 PM

10.40

+0.06 (0.58%)

After-hours: May 12, 2025, 7:31 PM EDT

BioCryst Pharmaceuticals Market Cap

BioCryst Pharmaceuticals has a market cap or net worth of $2.16 billion as of May 12, 2025. Its market cap has increased by 149.30% in one year.

Market Cap

2.16B

Enterprise Value

2.70B

1-Year Change

149.30%

Ranking

#1846

Market Cap Chart

Since December 1, 1998, BioCryst Pharmaceuticals's market cap has increased from $100.40M to $2.16B, an increase of 2,055.03%. That is a compound annual growth rate of 12.31%.

Market Cap History

Date	Market Cap	% Change
May 9, 2025	2.09B	33.94%
Dec 31, 2024	1.56B	26.96%
Dec 29, 2023	1.23B	-42.68%
Dec 30, 2022	2.14B	-14.12%
Dec 31, 2021	2.49B	89.46%
Dec 31, 2020	1.32B	245.25%
Dec 31, 2019	381.00M	-56.94%
Dec 31, 2018	884.80M	83.11%
Dec 29, 2017	483.20M	3.49%
Dec 30, 2016	466.90M	-38.31%
Dec 31, 2015	756.80M	-13.40%
Dec 31, 2014	873.90M	94.59%
Dec 31, 2013	449.10M	522.02%
Dec 31, 2012	72.20M	-35.36%
Dec 30, 2011	111.70M	-51.92%
Dec 31, 2010	232.30M	-7.38%
Dec 31, 2009	250.80M	378.63%
Dec 31, 2008	52.40M	-77.65%
Dec 31, 2007	234.50M	-30.60%
Dec 29, 2006	337.90M	-23.72%
Dec 30, 2005	443.00M	252.71%
Dec 31, 2004	125.60M	3.37%
Dec 31, 2003	121.50M	614.71%
Dec 31, 2002	17.00M	-75.61%
Dec 31, 2001	69.70M	-40.02%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	659.45B
Johnson & Johnson	371.06B
UnitedHealth Group	345.29B
AbbVie	326.55B
Novo Nordisk	297.79B
Abbott Laboratories	231.82B
Novartis AG	214.71B
AstraZeneca	211.14B

Market Cap Rankings